Taurine protects against NMDA-induced retinal damage by reducing retinal oxidative stress
- 69 Downloads
This study aimed to evaluate effect of TAU on NMDA-induced changes in retinal redox status, retinal cell apoptosis and retinal morphology in Sprague–Dawley rats. Taurine was injected intravitreally as pre-, co- or post-treatment with NMDA and 7 days post-treatment retinae were processed for estimation of oxidative stress, retinal morphology using H&E staining and retinal cell apoptosis using TUNEL staining. Treatment with TAU, particularly pre-treatment, significantly increased retinal glutathione, superoxide dismutase and catalase levels compared to NMDA-treated rats; whereas, the levels of malondialdehyde reduced significantly. Reduction in retinal oxidative stress in TAU pre-treated group was associated with significantly greater fractional thickness of ganglion cell layer within inner retina and retinal cell density in inner retina. TUNEL staining showed significantly reduced apoptotic cell count in TAU pre-treated group compared to NMDA group. It could be concluded that TAU protects against NMDA-induced retinal injury in rats by reducing retinal oxidative stress.
KeywordsNMDA Taurine Retina Oxidative stress
Ganglion cell layer
Nitric oxide synthase
We acknowledge the administrative and facility support by Research Management Institute, Institute of Medical Molecular Biotechnology (IMMB) and Laboratory Animal Care Unit, Universiti Teknologi MARA, Malaysia. The authors also acknowledge the financial support by Universiti Teknologi MARA, Malaysia, under Grant no. 600-IRMI/DANA 5/3/Bestari (P) (003/2018).
Compliance with ethical standards
Conflict of interest
Authors declare that no conflicts of interest exist.
The study was approved by The Committee of Animal Research and Ethics (UiTM CARE). Study was done in Compliance with the local institutional ethical guidelines and according to ARVO statement for ophthalmic and vision research.
- Arfuzir NN, Lambuk L, Jafri AJ, Agarwal R, Iezhitsa I, Sidek S, Agarwal P, Bakar NS, Kutty MK, Yusof AP, Krasilnikova A, Spasov A, Ozerov A, Mohd Ismail N (2016) Protective effect of magnesium acetyltaurate against endothelin-induced retinal and optic nerve injury. Neuroscience 325:153–164CrossRefGoogle Scholar
- Ishikawa M (2013) Abnormalities in glutamate metabolism and excitotoxicity in the retinal diseases. Scientifica (Cairo) 2013:528940Google Scholar
- Jafri AJA, Arfuzir NNN, Lambuk L, Iezhitsa I, Agarwal R, Agarwal P, Razali N, Krasilnikova A, Kharitonova M, Demidov V, Serebryansky E, Skalny A, Spasov A, Yusof APM, Ismail NM (2017) Protective effect of magnesium acetyltaurate against NMDA-induced retinal damage involves restoration of minerals and trace elements homeostasis. J Trace Elem Med Biol 39:147–154CrossRefGoogle Scholar
- Jafri AJA, Agarwal R, Iezhitsa I, Agarwal P, Spasov A, Ozerov A, Ismail NM (2018) Protective effect of magnesium acetyltaurate and taurine against NMDA-induced retinal damage involves reduced nitrosative stress. Mol Vis 24:495–508Google Scholar
- Lambuk L, Jafri AJ, Arfuzir NN, Iezhitsa I, Agarwal R, Rozali KN, Agarwal P, Bakar NS, Kutty MK, Yusof AP, Krasilnikova A, Spasov A, Ozerov A, Ismail NM (2017) Neuroprotective effect of magnesium acetyltaurate against NMDA-induced excitotoxicity in rat retina. Neurotox Res 31:31–45CrossRefGoogle Scholar
- Mohd Lazaldin MA, Iezhitsa I, Agarwal R, Bakar NS, Agarwal P, Mohd Ismail N (2018) Time- and dose-related effects of amyloid beta1–40 on retina and optic nerve morphology in rats. Int J Neurosci 20:1–14Google Scholar
- Nonaka H, Tsujino T, Watari Y, Emoto N, Yokoyama M (2001) Taurine prevents the decrease in expression and secretion of extracellular superoxide dismutase induced by homocysteine: amelioration of homocysteine-induced endoplasmic reticulum stress by taurine. Circulation 104:1165–1170CrossRefGoogle Scholar
- Ripps H, Shen W (2012) Review: taurine: a “very essential” amino acid. Mol Vis 18:2673–2686Google Scholar
- Yarbrough GG, Singh DK, Taylor DA (1981) Neuropharmacological characterization of a taurine antagonist. J Pharmacol Exp Ther 219:604–613Google Scholar